A decade of oncology drug development: FDA-approved drug trends between 2005 and 2015

被引：0
|
作者：
Asabere, Akwasi [1 ]
Bastian, Alex [1 ]
机构：
[1] GfK Market Access, San Francisco, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e17788
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17788
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Analysis of lomustine drug content in FDA-approved and compounded lomustine capsules
    KuKanich, Butch
    Warner, Matt
    Hahn, Kevin
    JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2017, 250 (03): : 322 - 326
  • [42] Applications of promiscuity of FDA-approved kinase inhibitors in drug repositioning and toxicity
    Korikani, Meghana
    Fathima, Neeshat
    Nadiminti, Gouthami
    Akula, Sravani
    Kancha, Rama Krishna
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2023, 465
  • [43] Primary Care Physicians' Use of FDA-Approved Prescription Drug Labels
    Sullivan, Helen W.
    O'Donoghue, Amie C.
    Aikin, Kathryn J.
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2014, 27 (05) : 694 - 698
  • [44] Lomustine drug content in FDA-approved versus compounded capsules responce
    KuKanich, Butch
    JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2017, 250 (06): : 607 - 608
  • [45] Omaveloxolone: a groundbreaking milestone as the first FDA-approved drug for Friedreich ataxia
    Pilotto, Federica
    Chellapandi, Deepika M.
    Puccio, Helene
    TRENDS IN MOLECULAR MEDICINE, 2024, 30 (02) : 117 - 125
  • [46] FDA-approved drug could boost cancer vaccine's efficacy
    Purslow, Caroline
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (07) : 867 - 867
  • [47] Selumetinib-A Comprehensive Review of the New FDA-Approved Drug for Neurofibromatosis
    Gorai, Surajit
    Rathore, Gyanesh
    Das, Kinnor
    INDIAN DERMATOLOGY ONLINE JOURNAL, 2024, 15 (04) : 701 - 705
  • [48] Prices and Trends in FDA-Approved Medications for Sarcomas
    Hwang, Caleb
    Agulnik, Mark
    Schulte, Brian
    CANCERS, 2024, 16 (08)
  • [49] Trends and progress of oncology drug development - An analysis of the FDA oncologic drug advisory committee reviews
    Amanam, I.
    Kiet, T.
    Young-Lin, N.
    Chen, L.
    Brooks, R.
    Ueda, S.
    Monk, B.
    Kapp, D.
    Hoth, D.
    Chan, J.
    GYNECOLOGIC ONCOLOGY, 2012, 127 (01) : S11 - S12
  • [50] Consideration of Potential Drug-Drug Interactions in Selection of FDA-Approved Drugs Indicated for Prostate Cancer
    Pilon, Dominic
    Ellis, Lorie A.
    Xiao, Yongling
    Behl, Ajay S.
    Lefebvre, Patrick
    AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (03) : E422 - E424
12345